GlycoMimetics (FRA:GKO) Short-Term Capital Lease Obligation : €0.58 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is GlycoMimetics Short-Term Capital Lease Obligation?

GlycoMimetics's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.58 Mil.

GlycoMimetics's quarterly Short-Term Capital Lease Obligation declined from Sep. 2023 (€0.70 Mil) to Dec. 2023 (€0.68 Mil) and declined from Dec. 2023 (€0.68 Mil) to Mar. 2024 (€0.58 Mil).

GlycoMimetics's annual Short-Term Capital Lease Obligation declined from Dec. 2021 (€0.89 Mil) to Dec. 2022 (€0.87 Mil) and declined from Dec. 2022 (€0.87 Mil) to Dec. 2023 (€0.68 Mil).

GlycoMimetics Short-Term Capital Lease Obligation Historical Data

The historical data trend for GlycoMimetics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlycoMimetics Short-Term Capital Lease Obligation Chart

GlycoMimetics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.72

0.74

0.89

0.87

0.68

GlycoMimetics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.61	0.76	0.70	0.68	0.58

GlycoMimetics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

GlycoMimetics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of GlycoMimetics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

GlycoMimetics (FRA:GKO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GlycoMimetics Inc (FRA:GKO) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

GLYC:USA

Address

9708 Medical Center Drive, Rockville, MD, USA, 20850

Website

https://www.glycomimetics.com

GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.